PTE PolarityTE Allowance for First U.S. Patent

PolarityTE first patent allowance in the United States. This patent application covers methods of making compositions for regenerating functional skin tissue using the Company’s minimally polarized functional unit (MPFU) technology.
The Company continues to prosecute additional patent applications in the United States and abroad related to its regenerative technologies and SkinTE®. (businesswire.com)

Analyst Ratings PTE Price Target: 421.72% upside
Market Cap of only 34.265M
Total revenues were $3.34 million in Q3:20 compared to $1. 40 million in Q3:19
SkinTE revenues were $1.16 million in Q3:20 compared to $0.84 million in Q3:19
Contract services revenues were $2.18 million in Q3:20 and includes $1.75 million from COVID-19 testing

The indicators signal Buy recommendations on most timeframes!

If you are interested to test some amazing BUY and SELL INDICATORS that i use, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.